Last year, the export of traditional Chinese medicine reached 1.9 billion US dollars, and extracts became the main force

China's export of traditional Chinese medicine broke through again in 2010, reaching US $1.944 billion The export of traditional Chinese medicine has four characteristics The reporter learned from China Chamber of Commerce for the import and export of medical and health products that in 2010, the import and export volume of Chinese traditional medicine products reached 2.632 billion US dollars, an increase of 22.74% year on year Among them, the export value was US $1.944 billion, up 22.78% year on year, and the import value was US $688 million, up 22.61% year on year The export growth of Chinese Herbal Pieces ranked second with the price increase decreasing Influenced by the price increase of domestic traditional Chinese medicine, the export of Chinese medicine Pieces increased in 2010, with the average export price increasing by 13.4% year on year In 2010, the export volume of Chinese herbal pieces was 776 million US dollars, an increase of 28.07% year on year, accounting for 39.89% of the total export volume of Chinese herbal products But the turnover of Fritillaria, notoginseng, Cordyceps sinensis, Coptis, Atractylodes macrocephala and other medicinal materials with soaring prices also generally shrank by 30-40% The trade deficit of Chinese patent medicine has increased, and the export growth to the EU has declined sharply In 2010, Chinese patent medicines have been exported to 143 countries and regions, with an export volume of 193 million US dollars, an increase of 18.05% year on year, and an import volume of 218 million US dollars, an increase of 23.71% year on year The trade deficit of Chinese patent medicine has increased since 2008 and 2010 Singapore, Malaysia and Hong Kong are the countries with a large increase in the export of Chinese patent medicines Hong Kong, Japan and the United States are still the main export markets of Chinese patent medicines, accounting for about 57% of China's export of Chinese patent medicines Hong Kong has become a transit point for the export of Chinese patent medicines to the world The main import sources of Chinese patent medicine are Germany, Hong Kong and Japan At the same time, affected by the implementation of the EU registration procedure for traditional botanical drugs on April 30, 2011, the export of Chinese patent medicines to the EU increased by only 15% year on year in 2010, far less than the annual growth rate of 25% of China's export of Chinese patent medicines to the EU in previous years The export of extract is still the main force, accounting for 40% In 2010, China's export volume of extract reached US $815 million, a year-on-year increase of 17.62%, accounting for 41.92% of the total export volume of traditional Chinese medicine The export volume of extract maintained a growth trend, accounting for the first place in the export volume of traditional Chinese medicine for many consecutive years The import volume of extract reached US $130 million, a year-on-year increase of 7.16%, accounting for 18.95% of the total import volume of traditional Chinese medicine In 2010, China's main export markets of plant extracts are still Japan and the United States, with Germany, France and the United Kingdom as the main EU countries increasing by more than 60% It shows that the international demand for plant extracts is still strong The export growth of health care products is the largest, and the import is still larger than the export In 2010, China's export of health care products reached US $161 million, an increase of 32.27% year on year, and its import reached US $203 million, an increase of 30.33% year on year There are 98 export countries and regions, among which the United States, Vietnam and Indonesia are the countries with large export growth The United States and Japan are the major export countries, accounting for more than 60% of China's health products exports, but the growth of exports to Japan has slowed down in recent years The main export products are fish oil, inositol, seaweed and royal jelly The import and export of health care products increased the most year-on-year in the trade of traditional Chinese medicine, but it still showed a large deficit, reaching a record high of 42 million US dollars According to the analysis of China Chamber of Commerce for the import and export of health care products, in 2011, with the continuous growth of the demand for green products in the international market, the export of traditional Chinese medicine products will continue to increase, and the dominant products are mainly plant extracts, Chinese herbal pieces and health care products While the international market continues to maintain a strong demand for Chinese traditional medicine products, we also need to see the introduction of the cGMP decree of the United States, the implementation of electronic database verification management for the import of Korean traditional Chinese medicine, the implementation of the EU registration procedure for traditional plant medicine and other legal measures, which can be described as the "examination paper" placed in front of Chinese medicine enterprises, and become an important part of the Chinese medicine industry in 2011 and for some time to come Important issues to be solved.